AI blood test finds silent liver disease years before symptoms

Researchers at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI) driven liquid biopsy that analyzes genome wide patterns of cell free DNA (cfDNA) fragments circulating in the blood. The test examines how these DNA pieces break apart and where they appear across the genome. Using this information, the system can identify early signs of liver fibrosis and cirrhosis and may also detect broader indicators of chronic disease.

1. Homepage
2. Science
3. AI blood test finds silent liver disease years before symptoms